Jeff Yass’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-20,512
| Closed | -$6K | – | 14475 |
|
|
2022
Q3 | $6K | Sell |
20,512
-4,539
| -18% | -$1.98K | ﹤0.01% | 12876 |
|
|
2022
Q2 | $19K | Sell |
25,051
-472
| -2% | -$421 | ﹤0.01% | 12383 |
|
|
2022
Q1 | $27K | Sell |
25,523
-53,323
| -68% | -$96.9K | ﹤0.01% | 12542 |
|
|
2021
Q4 | $149K | Sell |
78,846
-17,241
| -18% | -$41.3K | ﹤0.01% | 11801 |
|
|
2021
Q3 | $289K | Sell |
96,087
-107,716
| -53% | -$384K | ﹤0.01% | 10690 |
|
|
2021
Q2 | $797K | Buy |
203,803
+120,186
| +144% | +$498K | ﹤0.01% | 8390 |
|
|
2021
Q1 | $424K | Buy |
+83,617
| New | +$434K | ﹤0.01% | 9858 |
|
|
2020
Q2 | – | Sell |
-37,942
| Closed | -$174K | – | 11229 |
|
|
2020
Q1 | $124K | Buy |
37,942
+6,166
| +19% | +$32.5K | ﹤0.01% | 9170 |
|
|
2019
Q4 | $144K | Buy |
+31,776
| New | +$100K | ﹤0.01% | 8968 |
|
|
2019
Q1 | – | Sell |
-45,684
| Closed | -$160K | – | 10153 |
|
|
2018
Q4 | $114K | Buy |
+45,684
| New | +$268K | ﹤0.01% | 8158 |
|
|
2018
Q1 | – | Sell |
-13,496
| Closed | -$56.7K | – | 10457 |
|
|
2017
Q4 | $49K | Sell |
13,496
-3,033
| -18% | -$11.5K | ﹤0.01% | 8913 |
|
|
2017
Q3 | $65K | Sell |
16,529
-61,432
| -79% | -$282K | ﹤0.01% | 8485 |
|
|
2017
Q2 | $398K | Buy |
+77,961
| New | +$438K | ﹤0.01% | 7056 |
|
|
2017
Q1 | – | Sell |
-24,893
| Closed | -$194K | – | 10283 |
|
|
2016
Q4 | $233K | Buy |
+24,893
| New | +$224K | ﹤0.01% | 8422 |
|
Jeff Yass's AGTC Position: Q4 2022 in Review
Jeff Yass sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 20,512 shares — an estimated $6K sold.
Jeff Yass first reported a position in AGTC in Q4 2016 and held it in 14 quarters. The position peaked at $797K in Q2 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Jeff Yass reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Jeff Yass sold 20,512 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $6K.
- Jeff Yass first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 14 quarters.
- Jeff Yass's Applied Genetic Technologies Corporation position peaked at $797K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.